Roberto Piva
Roberto Piva
Verified email at
TitleCited byYear
The anaplastic lymphoma kinase in the pathogenesis of cancer
R Chiarle, C Voena, C Ambrogio, R Piva, G Inghirami
Nature Reviews Cancer 8 (1), 11, 2008
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
A Zamo, R Chiarle, R Piva, J Howes, Y Fan, M Chilosi, DE Levy, ...
Oncogene 21 (7), 1038, 2002
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib
R Piva, B Ruggeri, M Williams, G Costa, I Tamagno, D Ferrero, V Giai, ...
Blood 111 (5), 2765-2775, 2008
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors
R Chiarle, JZ Gong, I Guasparri, A Pesci, J Cai, J Liu, WJ Simmons, ...
Blood 101 (5), 1919-1927, 2003
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma
R Crescenzo, F Abate, E Lasorsa, M Gaudiano, N Chiesa, F Di Giacomo, ...
Cancer cell 27 (4), 516-532, 2015
NF-κB: a stress-regulated switch for cell survival
R Piva, G Belardo, MG Santoro
Antioxidants & redox signaling 8 (3-4), 478-486, 2006
Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis
C Atzori, B Ghetti, R Piva, AN Srinivasan, P Zolo, MB Delisle, SS Mirra, ...
Journal of Neuropathology & Experimental Neurology 60 (12), 1190-1197, 2001
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
R Piva, R Chiarle, AD Manazza, R Taulli, W Simmons, C Ambrogio, ...
Blood 107 (2), 689-697, 2006
c-Jun, JNK/SAPK kinases and transcription factor NF-κB are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis
A Migheli, R Piva, C Atzori, D Troost, D Schiffer
Journal of Neuropathology & Experimental Neurology 56 (12), 1314-1322, 1997
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes
R Piva, E Pellegrino, M Mattioli, L Agnelli, L Lombardi, F Boccalatte, ...
The Journal of clinical investigation 116 (12), 3171-3182, 2006
New and old functions of STAT3: a pivitol target for individualized treatment of cancer
G Inghirami, R Chiarle, WJ Simmons, R Piva, K Schlessinger, DE Levy
Cell cycle 4 (9), 1131-1133, 2005
Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms
R Piva, L Agnelli, E Pellegrino, K Todoerti, V Grosso, I Tamagno, ...
J Clin Oncol 28 (9), 1583-1590, 2010
S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase
R Chiarle, Y Fan, R Piva, H Boggino, J Skolnik, D Novero, G Palestro, ...
The American journal of pathology 160 (4), 1457-1466, 2002
Anaplastic lymphoma kinase in human cancer
A Barreca, E Lasorsa, L Riera, R Machiorlatti, R Piva, M Ponzoni, I Kwee, ...
Journal of molecular endocrinology 47 (1), R11-R23, 2011
15-Deoxy-Δ12, 14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-κB activity and down-regulation of antiapoptotic proteins
R Piva, P Gianferretti, A Ciucci, R Taulli, G Belardo, MG Santoro
Blood 105 (4), 1750-1758, 2005
Lack of apoptosis in mice with ALS
A Migheli, C Atzori, R Piva, M Tortarolo, M Girelli, D Schiffer, C Bendotti
Nature medicine 5 (9), 966, 1999
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study
PP Piccaluga, F Fuligni, A De Leo, C Bertuzzi, M Rossi, F Bacci, ...
Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice
C Bendotti, C Atzori, R Piva, M Tortarolo, MJ Strong, S Debiasi, A Migheli
Journal of Neuropathology & Experimental Neurology 63 (2), 113-119, 2004
Proteasome-dependent degradation of p27/kip1 in gliomas
R Piva, I Cancelli, P Cavalla, S Bortolotto, J Dominguez, GF Draetta, ...
Journal of neuropathology and experimental neurology 58 (7), 691-696, 1999
PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas
D Laimer, H Dolznig, K Kollmann, PW Vesely, M Schlederer, O Merkel, ...
Nature medicine 18 (11), 1699, 2012
The system can't perform the operation now. Try again later.
Articles 1–20